Tina Levstek

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Peritoneal Dialysis

Chronic Kidney Disease

End Stage Renal Disease

Prognostic Factors

Top Venues

Antioxidants (Basel, Switzerland)

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Sabina Ugovšek, Andreja Rehberger Likozar, Tina Levstek, Katarina Trebušak Podkrajšek, Janja Zupan, Miran Šebeštjen
Haplotype of the Lipoprotein(a) Gene Variants rs10455872 and rs3798220 Is Associated with Parameters of Coagulation, Fibrinolysis, and Inflammation in Patients after Myocardial Infarction and Highly Elevated Lipoprotein(a) Values. International journal of molecular sciences 25 (2) (2024)
Tina Levstek, Nika Breznik, Bojan Vujkovac, Albina Nowak, Katarina Trebušak Podkrajšek
Dynamics of Leukocyte Telomere Length in Patients with Fabry Disease. Biomedicines 12 (8) (2024)
Sabina Ugovšek, Andreja Rehberger Likozar, Tina Levstek, Katarina Trebušak Podkrajšek, Janja Zupan, Miran Šebeštjen
Haplotype of the Lipoprotein(a) Gene Variants rs10455872 and rs3798220 Is Associated with Parameters of Coagulation, Fibrinolysis, and Inflammation in Patients after Myocardial Infarction and Highly Elevated Lipoprotein(a) Values. International journal of molecular sciences 25 (2) (2024)
Tina Levstek, Nika Breznik, Bojan Vujkovac, Albina Nowak, Katarina Trebušak Podkrajšek
Dynamics of Leukocyte Telomere Length in Patients with Fabry Disease. Biomedicines 12 (8) (2024)
Sabina Ugovšek, Andreja Rehberger Likozar, Tina Levstek, Katarina Trebušak Podkrajšek, Janja Zupan, Miran Šebeštjen
Haplotype of the Lipoprotein(a) Gene Variants rs10455872 and rs3798220 Is Associated with Parameters of Coagulation, Fibrinolysis, and Inflammation in Patients after Myocardial Infarction and Highly Elevated Lipoprotein(a) Values. International journal of molecular sciences 25 (2) (2024)
Tina Levstek, Tina Karun, Andreja Rehberger Likozar, Miran Šebeštjen, Katarina Trebušak Podkrajšek
Interplay between microRNAs, Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9), and Lipid Parameters in Patients with Very High Lipoprotein(a) Treated with PCSK9 Inhibitors. Genes 14 (3) (2023)
Tina Levstek, Katarina Trebušak Podkrajšek
Telomere Attrition in Chronic Kidney Diseases. Antioxidants (Basel, Switzerland) 12 (3) (2023)
Tina Levstek, Katarina Trebušak Podkrajšek
Telomere Attrition in Chronic Kidney Diseases. Antioxidants (Basel, Switzerland) 12 (3) (2023)
Tina Levstek, Tina Karun, Andreja Rehberger Likozar, Miran Šebeštjen, Katarina Trebušak Podkrajšek
Interplay between microRNAs, Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9), and Lipid Parameters in Patients with Very High Lipoprotein(a) Treated with PCSK9 Inhibitors. Genes 14 (3) (2023)
Tina Levstek, Tina Karun, Andreja Rehberger Likozar, Miran Šebeštjen, Katarina Trebušak Podkrajšek
Interplay between microRNAs, Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9), and Lipid Parameters in Patients with Very High Lipoprotein(a) Treated with PCSK9 Inhibitors. Genes 14 (3) (2023)
Tina Levstek, Nik Podkrajšek, Andreja Rehberger Likozar, Miran Šebeštjen, Katarina Trebušak Podkrajšek
The Influence of Treatment with PCSK9 Inhibitors and Variants in the CRP (rs1800947), TNFA (rs1800629), and IL6 (rs1800795) Genes on the Corresponding Inflammatory Markers in Patients with Very High Lipoprotein(a) Levels. Journal of cardiovascular development and disease 9 (5) (2022)
Tina Levstek, Teo Mlinšek, Marija Holcar, Katja Goričar, Metka Lenassi, Vita Dolzan, Bojan Vujkovac, Katarina Trebušak Podkrajšek
Urinary Extracellular Vesicles and Their miRNA Cargo in Patients with Fabry Nephropathy. Genes 12 (7) (2021)
Tina Levstek, Sara Redenšek, Maja Trošt, Vita Dolzan, Katarina Trebušak Podkrajšek
Assessment of the Telomere Length and Its Effect on the Symptomatology of Parkinson's Disease. Antioxidants (Basel, Switzerland) 10 (1) (2021)